| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 32 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 32 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 32 |
| 3 | RITUXIMAB | 31 |
| 4 | AXICABTAGENE CILOLEUCEL | 28 |
| 5 | PREDNISONE | 27 |
| 6 | DOXORUBICIN | 24 |
| 7 | DEXAMETHASONE | 14 |
| 8 | DEXAMETHASONE 1.5 MG | 14 |
| 9 | FLUDARABINE PHOSPHATE | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EPCORITAMAB-BYSP | 4 | 0.0030 |
| 1 | AXICABTAGENE CILOLEUCEL | 28 | 0.0028 |
| 2 | SILTUXIMAB | 1 | 0.0015 |
| 3 | ETOPOSIDE PHOSPHATE | 2 | 0.0012 |
| 4 | CHLOROTHIAZIDE SODIUM | 1 | 0.0011 |
| 5 | CHLOROTHIAZIDE | 1 | 0.0008 |
| 6 | POLATUZUMAB VEDOTIN | 8 | 0.0008 |
| 7 | VINORELBINE | 5 | 0.0007 |
| 8 | ARGATROBAN | 1 | 0.0007 |
| 9 | IBRITUMOMAB TIUXETAN | 1 | 0.0007 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD19-directed Chimeric Antigen Receptor [EPC] | 28 | 0.0028 |
| 1 | Interleukin-6 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 4 | 0.0010 |
| 3 | CD30-directed Immunoconjugate [EPC] | 4 | 0.0004 |
| 4 | Anti-coagulant [EPC] | 1 | 0.0003 |
| 5 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 6 | Alkylating Drug [EPC] | 32 | 0.0001 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 31 | 0.0001 |
| 8 | Topoisomerase Inhibitor [EPC] | 7 | 0.0001 |
| 9 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 1 | 0.0001 |